Key statistics
On Friday, Mural Oncology PLC (MURA:NMQ) closed at 3.35, 16.32% above the 52 week low of 2.88 set on Jul 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.37 |
---|---|
High | 3.38 |
Low | 3.28 |
Bid | 3.33 |
Offer | 3.41 |
Previous close | 3.37 |
Average volume | 72.76k |
---|---|
Shares outstanding | 17.04m |
Free float | 16.84m |
P/E (TTM) | -- |
Market cap | 57.42m USD |
EPS (TTM) | -9.14 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
- Mural Oncology Announces Publication Highlighting Promising Clinical Antitumor Activity Shown in its ARTISTRY-1 Clinical Trial of Nemvaleukin, its Lead Engineered Fusion Protein, in the Journal for ImmunoTherapy of Cancer
- Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress
- Mural Oncology to Participate in Two Upcoming Investor Conferences
- Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
- Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mural Oncology to Present Clinical and Preclinical Data at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
- Mural Oncology’s First Virtual Investor Day to Highlight Late-Stage Clinical Progress
- Mural Oncology Strengthens Board of Directors with the Appointment of Sachiyo Minegishi
- Mural Oncology to Host First Virtual Investor Day on September 26, 2024
- Mural Oncology to Present at Two Upcoming Investor Conferences
More ▼